{"name": "BTG",
 "permalink": "btg",
 "crunchbase_url": "http://www.crunchbase.com/company/btg",
 "homepage_url": "http://www.btgplc.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "customerservice@btgplc.com",
 "phone_number": "+44 (0)20 7575 0000 ",
 "description": "pharmaceuticals company",
 "created_at": "Tue Jun 01 10:06:11 UTC 2010",
 "updated_at": "Fri May 24 04:46:02 UTC 2013",
 "overview": "\u003Cp\u003EBTG is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists, and is building a sustainable business financed by revenues from sales of its critical care products and from royalties and milestone payments on partnered products.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[72,
       70],
      "assets/images/resized/0010/9706/109706v1-max-150x150.png"],
     [[72,
       70],
      "assets/images/resized/0010/9706/109706v1-max-250x250.png"],
     [[72,
       70],
      "assets/images/resized/0010/9706/109706v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "general manager",
    "person":
     {"first_name": "Steve",
      "last_name": "Baldwin",
      "permalink": "steve-baldwin",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [{"funding_round":
     {"round_code": "a",
      "source_url": "http://www.qunano.com/News\u0026Events/News/QuNano_seriesA_announcement_final.pdf",
      "source_description": "QuNano AB Announces Closing of Series A Financing Round",
      "raised_amount": 6100000.0,
      "raised_currency_code": "USD",
      "funded_year": 2006,
      "funded_month": 5,
      "funded_day": 19,
      "company":
       {"name": "QuNano",
        "permalink": "qunano",
        "image":
         {"available_sizes":
           [[[150,
              52],
             "assets/images/resized/0008/9122/89122v1-max-150x150.jpg"],
            [[242,
              84],
             "assets/images/resized/0008/9122/89122v1-max-250x250.jpg"],
            [[242,
              84],
             "assets/images/resized/0008/9122/89122v1-max-450x450.jpg"]],
          "attribution": null}}}}],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 242000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercebiotech.com/story/btg-buys-rival-242m/2010-11-19?utm_medium=rss\u0026utm_source=rss",
    "source_description": "BTG buys rival for $242M",
    "acquired_year": 2010,
    "acquired_month": 11,
    "acquired_day": 19,
    "company":
     {"name": "Biocompatibles International",
      "permalink": "biocompatibles-international",
      "image":
       {"available_sizes":
         [[[150,
            25],
           "assets/images/resized/0005/9613/59613v1-max-150x150.png"],
          [[250,
            42],
           "assets/images/resized/0005/9613/59613v1-max-250x250.png"],
          [[270,
            46],
           "assets/images/resized/0005/9613/59613v1-max-450x450.png"]],
        "attribution": null}}},
   {"price_amount": 220000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020130523e95nsn6sr\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020130523e95nsn6sr%26from%3dalert%26pid%3d32",
    "source_description": "BTG to Buy EKOS, Maker of Clot-Removing Device, for Up To $220M",
    "acquired_year": 2013,
    "acquired_month": 5,
    "acquired_day": 23,
    "company":
     {"name": "EKOS Corporation",
      "permalink": "ekos-corporation",
      "image":
       {"available_sizes":
         [[[150,
            76],
           "assets/images/resized/0008/4413/84413v1-max-150x150.jpg"],
          [[198,
            101],
           "assets/images/resized/0008/4413/84413v1-max-250x250.jpg"],
          [[198,
            101],
           "assets/images/resized/0008/4413/84413v1-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "HQ",
    "address1": "5 Fleet Place   ",
    "address2": "",
    "zip_code": "EC4M 7RD",
    "city": "London",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        123],
       "assets/images/resized/0010/9707/109707v1-max-150x150.jpg"],
      [[250,
        205],
       "assets/images/resized/0010/9707/109707v1-max-250x250.jpg"],
      [[450,
        369],
       "assets/images/resized/0010/9707/109707v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}